ArticlePharmaceutics2022

Preclinical Safety Evaluation of Intraperitoneally Administered Cu-Conjugated Anti-EGFR Antibody NCAB001 for the Early Diagnosis of Pancreatic Cancer Using PET.

Hiroki Matsumoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.